These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23288242)

  • 61. Three- to 5-year prospective follow-up of outcome in major depression.
    Van Londen L; Molenaar RP; Goekoop JG; Zwinderman AH; Rooijmans HG
    Psychol Med; 1998 May; 28(3):731-5. PubMed ID: 9626729
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The 341 737 ways of qualifying for the melancholic specifier.
    Fried EI; Coomans F; Lorenzo-Luaces L
    Lancet Psychiatry; 2020 Jun; 7(6):479-480. PubMed ID: 32445681
    [No Abstract]   [Full Text] [Related]  

  • 63. Baseline difference between patients' and clinicians' rated illness severity scores and subsequent outcomes in major depressive disorder: analysis of the sequenced treatment alternatives to relieve depression data.
    Tada M; Uchida H; Suzuki T; Abe T; Pollock BG; Mimura M
    J Clin Psychopharmacol; 2014 Jun; 34(3):297-302. PubMed ID: 24743720
    [No Abstract]   [Full Text] [Related]  

  • 64. Serum brain-derived neurotrophic factor and depressive symptoms in coronary heart disease patients: A word on methodology.
    Giannouli V
    Psychoneuroendocrinology; 2017 May; 79():175. PubMed ID: 28256361
    [No Abstract]   [Full Text] [Related]  

  • 65. Advanced Topics in Major Depressive Disorder: Practical Strategies to Improve Remission.
    Jain R
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29325240
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mathematical model for the distribution of major depressive episode durations.
    Tomitaka S; Furukawa TA
    BMC Res Notes; 2014 Sep; 7():636. PubMed ID: 25212048
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Implementing Measurement-Based Care to Determine and Treat Inadequate Response.
    Trivedi MH; Papakostas GI; Jackson WC; Rafeyan R
    J Clin Psychiatry; 2020 May; 81(3):. PubMed ID: 32369683
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients.
    Seemüller F; Obermeier M; Schennach R; Bauer M; Adli M; Brieger P; Laux G; Riedel M; Falkai P; Möller HJ
    BMC Psychiatry; 2016 May; 16():153. PubMed ID: 27206634
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Potential biomarkers of major depression diagnosis and chronicity.
    Galvão ACM; Almeida RN; de Sousa Júnior GM; Leocadio-Miguel MA; Palhano-Fontes F; de Araujo DB; Lobão-Soares B; Maia-de-Oliveira JP; Nunes EA; Hallak JEC; Sarris J; Galvão-Coelho NL
    PLoS One; 2021; 16(9):e0257251. PubMed ID: 34587177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Response to Uher et al.
    Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
    Am J Psychiatry; 2015 Apr; 172(4):396-8. PubMed ID: 25827040
    [No Abstract]   [Full Text] [Related]  

  • 71. Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression.
    Tadić A; Müller-Engling L; Schlicht KF; Kotsiari A; Dreimüller N; Kleimann A; Bleich S; Lieb K; Frieling H
    Mol Psychiatry; 2014 Mar; 19(3):281-3. PubMed ID: 23670489
    [No Abstract]   [Full Text] [Related]  

  • 72. Association of a brain methylation site with clinical outcomes in depression does not replicate across populations.
    Uher R; Ripke S; Müller-Myhsok B; Lewis CM; Perlis RH
    Am J Psychiatry; 2015 Apr; 172(4):395-7. PubMed ID: 25827039
    [No Abstract]   [Full Text] [Related]  

  • 73. Improving Remission Rates in Major Depressive Disorder: A Case-Based Approach.
    McIntyre RS
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29505192
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Can antidepressants act as potential pro-neoplastic agents in patients with neurotrophic factor-related cancers?
    Gau YT; Hong CJ; Tsai SJ
    CNS Spectr; 2008 Oct; 13(10):849-50. PubMed ID: 18955940
    [No Abstract]   [Full Text] [Related]  

  • 75. Inadequate Response to Antidepressant Treatment in Major Depressive Disorder.
    Papakostas GI; Jackson WC; Rafeyan R; Trivedi MH
    J Clin Psychiatry; 2020 May; 81(3):. PubMed ID: 32433833
    [No Abstract]   [Full Text] [Related]  

  • 76. BDNF and proBDNF as biomarkers for bipolar disorder.
    Hashimoto K
    Br J Psychiatry; 2014 Nov; 205(5):410. PubMed ID: 25368362
    [No Abstract]   [Full Text] [Related]  

  • 77. Remission as the "gold standard" of treatment for depression with and without physical symptoms.
    Fishbain DA
    J Clin Psychiatry; 2009 Apr; 70(4):e07. PubMed ID: 19403092
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapeutic possibility of "Semax" for depression.
    Pae CU
    CNS Spectr; 2008 Jan; 13(1):20-1. PubMed ID: 18204410
    [No Abstract]   [Full Text] [Related]  

  • 79. Molecular Biomarkers for Pediatric Depressive Disorders: A Narrative Review.
    Lee J; Chi S; Lee MS
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576215
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antidepressants: can't live with them, can't live without them.
    Nierenberg AA
    CNS Spectr; 2010 Mar; 15(3):146-7. PubMed ID: 20414162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.